LGALS3 and cancer: As Gal-3 and Gal-3bp are both involved in the metastatic process and were recently proposed as biomarkers38,39, we are confident that the presented system is an important step towards the phenotypic analysis of patient-derived tumour cells, which is necessary for the success of personalized cancer immunotherapies.